Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/ neu status
作者： Manuelito A Madrid , Raymundo W Lo
DOI: 10.1186/BCR915
关键词:
摘要: Background Chromogenic in situ hybridization (CISH) is emerging as a practical, cost-effective, and valid alternative to fluorescent testing for gene alteration, especially centers primarily working with immunohistochemistry (IHC).
biomedcentral.com
springer.com
breast-cancer-research.com
core.ac.uk参考文章(35)
D C Allred, G M Clark, K S Albain, Breast cancer outcome and predictors of outcome: are there age differentials? Journal of The National Cancer Institute Monographs. pp. 35- 42 ,(1994)
J A Fletcher, J S Ross, HER-2/neu (c-erb-B2) gene and protein in breast cancer. American Journal of Clinical Pathology. ,vol. 112, ,(1999)
B. Tetu, V. Plante, J. Brisson, P. Bernard, p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer. Modern Pathology. ,vol. 11, pp. 823- 830 ,(1998)
Godolphin W, Pauletti G, Press Mf, Slamon Dj, Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene. ,vol. 13, pp. 63- 72 ,(1996)
Luis Alberto Rubio-Martinez, José Maria Vera-Roman, Comparative assays for the HER-2/neu oncogene status in breast cancer. Archives of Pathology & Laboratory Medicine. ,vol. 128, pp. 627- 633 ,(2004) , 10.1043/1543-2165(2004)128<627:CAFTNO>2.0.CO;2
R.R. Tubbs, J.D. Pettay, P.C. Roche, M.H. Stoler, R.B. Jenkins, T.M. Grogan, Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the Message Journal of Clinical Oncology. ,vol. 19, pp. 2714- 2721 ,(2001) , 10.1200/JCO.2001.19.10.2714
C Carlomagno, F Perrone, C Gallo, M De Laurentiis, R Lauria, A Morabito, G Pettinato, L Panico, A D'Antonio, A R Bianco, S De Placido, c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. Journal of Clinical Oncology. ,vol. 14, pp. 2702- 2708 ,(1996) , 10.1200/JCO.1996.14.10.2702
TORILL SAUER, GRO WIEDSWANG, GHANIA BOUDJEMA, HANNE CHRISTENSEN, ROLF KARESEN, Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice? Apmis. ,vol. 111, pp. 444- 450 ,(2003) , 10.1034/J.1600-0463.2003.T01-1-1110210.X
Ian P. Corbett, James A. Henry, Brian Angus, Caroline J. Watchorn, Linda Wilkinson, Colm Hennessy, William J. Gullick, Nadia L. Tuzi, Felicity E. B. May, Bruce R. Westley, Charles H. W. Horne, NCL‐CB11, a new monoclonal antibody recognizing the internal domain of the c‐erbB‐2 oncogene protein effective for use on formalin‐fixed, paraffin‐embedded tissue The Journal of Pathology. ,vol. 161, pp. 15- 25 ,(1990) , 10.1002/PATH.1711610105
Nicholas C. Popescu, C.Richter King, Matthias H. Kraus, Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12–21.32 Genomics. ,vol. 4, pp. 362- 366 ,(1989) , 10.1016/0888-7543(89)90343-1